Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9353
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 331 $8,874,839 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $8,874,839 Current and potential, with all options
- Last date to order 84% complete
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide pharmaceutical products and medical supplies to support the Department of Defense (DoD) and other federal agencies. The IDC contract, valid through December 2026, covers a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.
This IDC is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple prime vendor contracts to provide worldwide pharmaceutical support to DoD customers, the U.S. Coast Guard, and other government agencies. The PPV-G GEN V solicitation, expected to be issued in March 2024, will have a total estimated value of $30.3 billion and will be awarded on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. The contracts will have a 30-month base period and three 30-month option periods, and awards will be made on a lowest price technically acceptable (LPTA) basis.
Task orders
Show 40 more
Latest 50 of 331 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D9353?
SPE2DR25D9353 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D9353 worth?
Orders under SPE2DR25D9353 have obligated $8,874,839.
How many orders have been placed under contract SPE2DR25D9353?
331 orders have been placed under SPE2DR25D9353, the latest on July 28, 2026.
Who can order from contract SPE2DR25D9353?
SPE2DR25D9353 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9353 competed?
The extent of competition for SPE2DR25D9353 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV